Biofrontera Inc. BFRI
1.18
(0.02)
(1.67%)
as of 25 Sep
- Market cap
- $17.8M
- P/E
- 0.0×
Follow BFRI
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(1,191.73%) | (141.30%) | (339.04%) | (988.35%) | |
| (103.57%) | (41.59%) | (53.58%) | (28.80%) | ||
ROIC |
0.00% | (81.82%) | (155.74%) | (69.45%) | |
Return on Tangible Assets |
(934.68%) | (126.24%) | (251.30%) | (157.82%) | |
Average Days of Receivables |
29.41 | 63.81 | 32.77 | 43.83 | |
Free Cash Flow per Share |
(1.11) | (1.31) | (0.80) | (0.61) | |
Free Cash Flow |
(12.01) | (13.36) | (9.32) | (7.93) | |
Capital Expenditures |
0.00 | 0.00 | 0.00 | 0.00 | |
Piotroski F-Score |
3.00 | 4.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(226.11%) | (62.23%) | (54.42%) | (52.00%) | |
Accounts Receivable Turnover |
9.45 | 6.62 | 10.92 | 9.72 | |
Accounts Payable Turnover |
2.32 | 1.58 | 1.80 | 1.86 | |
Inventory Turnover |
2.44 | 2.72 | 2.53 | 3.74 | |
Average Days of Payables |
157.10 | 221.92 | 184.10 | 204.18 | |
Days of Inventory on Hand |
119.46 | 47.47 | 45.79 | 41.80 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.01 | |
Research and Development Expense of Revenue |
9.99% | 8.92% | 7.90% | 6.48% | |
Selling, General and Administrative Expense of Revenue |
101.82% | 92.00% | 94.22% | 86.15% | |
Share Based Compensation of Revenue |
2.59% | 2.28% | 2.44% | 2.45% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.68 | 1.27 | 0.84 | 1.25 | |
Depreciation/Fixed assets |
43.45 | 0.40 | 0.38 | 0.38 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
3.45 | 4.10 | 3.70 | 3.57 | |
Operating CF per Share |
(1.11) | (1.31) | (0.80) | (0.61) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(47.28%) | (25.26%) | (25.66%) | (13.78%) |
Columns are period end dates